Swiss National Bank trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,896,300 shares of the biopharmaceutical company’s stock after selling 115,900 shares during the period. Swiss […]